Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie
Grantová podpora
MR/N003403/1
Medical Research Council - United Kingdom
PubMed
27864607
DOI
10.1007/s00330-016-4620-z
PII: 10.1007/s00330-016-4620-z
Knihovny.cz E-zdroje
- Klíčová slova
- Adverse events, Angiography, Comparative effectiveness, Computed tomography, Invasive coronary angiography,
- MeSH
- analýza nákladů a výnosů MeSH
- hodnocení výsledků zdravotní péče * MeSH
- koronární angiografie metody MeSH
- kvalita života MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- nemoci koronárních tepen diagnóza ekonomika MeSH
- pilotní projekty MeSH
- počítačová rentgenová tomografie metody MeSH
- retrospektivní studie MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- Geografické názvy
- Evropa MeSH
OBJECTIVES: More than 3.5 million invasive coronary angiographies (ICA) are performed in Europe annually. Approximately 2 million of these invasive procedures might be reduced by noninvasive tests because no coronary intervention is performed. Computed tomography (CT) is the most accurate noninvasive test for detection and exclusion of coronary artery disease (CAD). To investigate the comparative effectiveness of CT and ICA, we designed the European pragmatic multicentre DISCHARGE trial funded by the 7th Framework Programme of the European Union (EC-GA 603266). METHODS: In this trial, patients with a low-to-intermediate pretest probability (10-60 %) of suspected CAD and a clinical indication for ICA because of stable chest pain will be randomised in a 1-to-1 ratio to CT or ICA. CT and ICA findings guide subsequent management decisions by the local heart teams according to current evidence and European guidelines. RESULTS: Major adverse cardiovascular events (MACE) defined as cardiovascular death, myocardial infarction and stroke as a composite endpoint will be the primary outcome measure. Secondary and other outcomes include cost-effectiveness, radiation exposure, health-related quality of life (HRQoL), socioeconomic status, lifestyle, adverse events related to CT/ICA, and gender differences. CONCLUSIONS: The DISCHARGE trial will assess the comparative effectiveness of CT and ICA. KEY POINTS: • Coronary artery disease (CAD) is a major cause of morbidity and mortality. • Invasive coronary angiography (ICA) is the reference standard for detection of CAD. • Noninvasive computed tomography angiography excludes CAD with high sensitivity. • CT may effectively reduce the approximately 2 million negative ICAs in Europe. • DISCHARGE addresses this hypothesis in patients with low-to-intermediate pretest probability for CAD.
Basque Office for Health Technology Assessment Donostia San Sebastian 1 01010 Vitoria Gasteiz Spain
Department of Cardiology Aintree University Hospital Longmoor Lane L9 7AL Liverpool UK
Department of Cardiology ALB FILS KLINIKEN GmbH Eichertstrasse 3 73035 Goeppingen Germany
Department of Cardiology Azienda Ospedaliera Brotzu Cagliari CA Italy
Department of Cardiology Basurto University Hospital Avenida Montevideo 18 48013 Bilbao Spain
Department of Cardiology Cardio Med Medical Center 22 decembrie 1989 540156 Targu Mures Romania
Department of Cardiology Charité Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
Department of Cardiology Clinical Hospital Center Zemun Vukova 9 11080 Belgrade Zemun Serbia
Department of Cardiology Lithuanian University of Health Sciences Eivelniu 2 50009 Kaunas Lithuania
Department of Cardiology Medical University Innsbruck Anichstr 35 6020 Innsbruck Austria
Department of Cardiology Rigshospitalet Region Hovedstaden Rigshospitalet 9 2100 Copenhagen Denmark
Department of Cardiology St Vincent's University Hospital Belfield Campus 4 Dublin Ireland
Department of Cardiology The Institute of Cardiology in Warsaw Ul Alpejska 42 04 628 Warsaw Poland
Department of Cardiology University Hospital Motol Vuvalu 84 150 06 Prague 5 Czech Republic
Department of Radiology Aintree University Hospital Longmoor Lane L9 7AL Liverpool UK
Department of Radiology Basurto University Hospital Avenida Montevideo 18 48013 Bilbao Spain
Department of Radiology Charité Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
Department of Radiology Leiden University Medical Center Albinusdreef 2 2333 ZA Leiden Netherlands
Department of Radiology Lithuanian University of Health Sciences Eivelniu 2 50009 Kaunas Lithuania
Department of Radiology Medical University Innsbruck Anichstr 35 6020 Innsbruck Austria
Department of Radiology Sapienza University of Rome Viale Regina Elena 324 00161 Rome Italy
Department of Radiology The Institute of Cardiology in Warsaw Ul Alpejska 42 04 628 Warsaw Poland
Department of Radiology University Hospital Motol Vuvalu 84 150 06 Prague 5 Czech Republic
Department of Radiology University of Leipzig Heart Centre Strümpellstrasse 39 04289 Leipzig Germany
European Clinical Research Infrastructure Network Management Office 5 Rue Watt 75013 Paris France
Heart Centre Turku University Hospital Kiinamyllynkatu 4 8 FI 20120 Turku Finland
Institute of Public Health Charité Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
Zobrazit více v PubMed
BMJ. 2013 Jan 08;346:e7586 PubMed
J Am Coll Cardiol. 2016 Apr 19;67(15):1759-1768 PubMed
Eur Radiol. 2011 Sep;21(9):1904-13 PubMed
EuroIntervention. 2010 Jun;6(2):189-94 PubMed
Ann Intern Med. 2013 Feb 5;158(3):200-7 PubMed
J Clin Epidemiol. 1999 Jan;52(1):19-26 PubMed
Pharmacoeconomics. 2010;28(10):969-76 PubMed
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):981-9 PubMed
BMJ. 2016 Oct 24;355:i5441 PubMed
JAMA. 2003 Sep 24;290(12):1624-32 PubMed
J Am Coll Cardiol. 1999 May;33(6):1756-824 PubMed
JACC Cardiovasc Imaging. 2015 Dec;8(12 ):1404-1413 PubMed
Eur Radiol. 2007 May;17 (5):1301-9 PubMed
Eur Heart J. 2013 Oct;34(38):2949-3003 PubMed
Acta Psychiatr Scand. 1983 Jun;67(6):361-70 PubMed
JACC Cardiovasc Imaging. 2013 Jun;6(6):641-50 PubMed
Health Policy. 1990 Dec;16(3):199-208 PubMed
Lancet. 2015 Jun 13;385(9985):2383-91 PubMed
Value Health. 2015 Mar;18(2):161-72 PubMed
Eur Heart J. 2012 Jul;33(13):1635-701 PubMed
Stat Methods Med Res. 1999 Mar;8(1):3-15 PubMed
Eur Heart J. 2006 Jun;27(11):1341-81 PubMed
BMJ. 2012 Oct 24;345:e6717 PubMed
J Health Serv Res Policy. 2008 Oct;13 Suppl 3:23-30 PubMed
Rofo. 2010 Jul;182(7):589-93 PubMed
Circulation. 2009 Sep 8;120(10 ):867-75 PubMed
CMAJ. 2009 May 12;180(10):E47-57 PubMed
N Engl J Med. 2010 Mar 11;362(10 ):886-95 PubMed
J Epidemiol Community Health. 2003 Jul;57(7):538-41 PubMed
J Am Coll Cardiol. 2008 Feb 19;51(7):701-7 PubMed
Int J Cardiol. 2013 Aug 20;167(4):1268-75 PubMed
Syst Rev. 2013 Feb 15;2:13 PubMed
Ann Intern Med. 2011 Mar 15;154(6):413-20 PubMed
N Engl J Med. 2015 Apr 2;372(14):1291-300 PubMed
Ann Intern Med. 2010 Feb 2;152(3):167-77 PubMed
Cathet Cardiovasc Diagn. 1991 Oct;24(2):75-83 PubMed